---
title: "Merck Reportedly Goes To Bat In Takeover Battle. Genomics Stock Flies."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293053295.md"
description: "The stock of Personalis surged on Friday in response to speculation that Merck, along with two other potential buyers, is interested in acquiring the small genomics company. Reports suggest Merck has entered a takeover battle. The genomics stock experienced a significant increase in value as a result."
datetime: "2026-07-17T14:39:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293053295.md)
  - [en](https://longbridge.com/en/news/293053295.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293053295.md)
---

# Merck Reportedly Goes To Bat In Takeover Battle. Genomics Stock Flies.

The stock of Personalis surged on Friday in response to speculation that Merck, along with two other potential buyers, is interested in acquiring the small genomics company. Reports suggest Merck has entered a takeover battle. The genomics stock experienced a significant increase in value as a result.

### Related Stocks

- [PSNL.US](https://longbridge.com/en/quote/PSNL.US.md)
- [MKKGY.US](https://longbridge.com/en/quote/MKKGY.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)

## Related News & Research

- [Merck KGaA (OTCMKTS:MKKGY) Short Interest Update](https://longbridge.com/en/news/293802891.md)
- [Aspen Pharmacare signs voluntary licensing deal with MSD for once-monthly HIV prevention pill MK-8527](https://longbridge.com/en/news/293755123.md)
- [Personalis is said to have attracted takeover interest from Merck](https://longbridge.com/en/news/293038787.md)
- [Merck wins first approval of a PCSK9 cholesterol pill](https://longbridge.com/en/news/293238655.md)
- [FDA approves MSD’s Keytruda combinations for MIBC](https://longbridge.com/en/news/292462196.md)